Symposium
Wed. May 19, 2021 9:50 AM - 11:50 AM Room 05 (ICC Kyoto 2F Room B-1)
Chair：Pearson Christopher E.(The Hospital for Sick Children),Okada Yohei(Aichi Medical University, Department of Neurology)
Recent progress in stem cell biologies, iPSC technologies, and techniques for genetic modification and regulation have strong impacts on the development of novel therapeutics for intractable neurological disorders. In particular, findings in these fields raise expectations for breakthrough approaches for novel disease modifying therapies. In this symposium, four speakers will be invited to discuss novel therapeutic strategies for neurological disorders, focusing on neural regeneration by adult neurogenesis, disease modeling and drug discovery using disease specific iPSCs, and novel therapeutic gene modifications.
○Christopher E. Pearson (The Hospital for Sick Children)
Schedule
Like
)
○Kazunobu Sawamoto1,2 (1.Department of Developmental and Regenerative Neurobiology, Institute of Brain Science, Nagoya City University Graduate School of Medical Sciences, Japan, 2.Division of Neural Development and Regeneration, National Institute for Physiological Sciences, Japan)
Schedule
Like
)
○Yohei Okada (Aichi Medical University, Department of Neurology, Japan)
Schedule
Like
)
○Haruhisa Inoue1,2 (1.Center for iPS Cell Research and Application, Kyoto University, Japan, 2.RIKEN, Japan)
Schedule
Like
)